Immunic, Inc.
IMUX· Nasdaq
Released Nov 3, 2016, after the close
10-Q filed Nov 3, 2016, 34 days after period end · 0001280776-16-000026
| Metric | Q3 2016 | Q3 2015 | Q3 2014 | Q3 2013 |
|---|---|---|---|---|
| Net Income | -$10.18M | -$12.30M | -$12.80M | -$6.98M |
| EPS Diluted | -$0.32 | -$0.51 | -$0.59 | -$16.31 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Immunic, Inc. · CIK 1280776 · Engraved from SEC EDGAR